[Study on the factors influencing the quality of life among patients with malignant lymphoma].
OBJECTIVE
To measure and assess the quality of life (QOL) and to explore the influencing factors on patients with malignant lymphoma.


METHODS
QOL of 110 patients with malignant lymphoma were marked using EORTC QLQ-C30 short form, and multiple linear regression models were used to study the main factors influencing the QOL of patients with malignant lymphoma on five functional scales (physical, role, cognitive, emotional, and social) and the total scores.


RESULTS
The influencing factors of quality of life on patients with malignant lymphoma appeared to be: history of relapse, refraining from smoking, older age, educational level, space for living, exercises, medical care system, and available health care programs. Relapse (beta = 5.997, P= 0.020) and refraining from smoking (beta = -6.526, P= 0.006) were associated with total QOL scores, educational level (beta = -2.144, P= 0.057), History of relapse (beta = 5.857, P = 0.003) was associated with total functional scales while exercises (beta= -0.771, P = 0.097) and refraining from smoking (beta= -4.106, P = 0.005) were with physical scales, refraining from smoking (beta = -4.644,P = 0.008) and older age (beta = 0.989, P= 0.029) were with role scales, relapse (beta = 14.035, P= 0.001) and older age (beta = 2.230, P= 0.023) were with cognitive scales, relapse (beta = 8.500, P= 0.031) and living space (beta = - 3.054, P= 0.0901) were with emotional scales and medical care system and available health care programs (beta = -6.577, P= 0.018) were with social scales respectively.


CONCLUSIONS
Factors as prevention of relapse, correct cognition on malignant lymphoma, reasonable exercise, refrain from bad habits, improving medical care system could all increase the functions of malignant lymphoma patient, and to improve their quality of life.
Lv
Mei-xia
MX
Department of Epidemiology & Statistics, School of Public Health, Tongji Medical College, Huazhong University of Science & Health Technology, Wuhan 430030, China.
Duan
Qiong-hong
QH
Shi
Lv-yuan
LY
Gu
Yuan
Y
Zhang
Hui-juan
HJ
Ran
Peng
P
D003071:Cognition; D006801:Humans; D008223:Lymphoma / Q000503:physiopathology* / Q000523:psychology; D011788:Quality of Life; D012008:Recurrence